Eidos Therapeutics Inc (EIDX)


Stock Price Forecast

Jan. 25, 2021


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Eidos Therapeutics Inc chart...

About the Company

We do not have any company description for Eidos Therapeutics Inc at the moment.

Please visit http://eidostx.com for more information about the company.

CEO

Neil Kumar

Exchange

NASDAQ/NGS (GLOBAL SELECT MARKET)

Website

http://eidostx.com

$0M

Total Revenue

45

Employees

$5B

Market Capitalization

-46.12

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $EIDX News

Bayer (BAYRY) Banks on Pipeline Progress Amid Challenges

3d ago, source: Zacks.com on MSN

Bayer AG BAYRY presented the latest developments on the road to transform its pharma business to drive growth on its annual Pharma Media Day 2024. The company is now primarily focused on four core ...

BridgeBio Pharma: Assessing Acoramidis' Market Opportunity, Further Upside Potential Evident

7d ago, source:

BridgeBio's acoramidis seems likely to secure approval in November, in the large market of ATTR-cardiomyopathy. Read more to ...

UPDATE 2-Seelos Therapeutics' ALS treatment fails mid-stage study

on MSN ago, source:

Shares of the New York-based company plunged about 52% to 44 cents, hitting a record low. The drug, SLS-005, when tested in 120 patients, failed to show statistically significant improvement in motor ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...